IP Library Granted Patent US 10,538,509
Granted Patent B2
US 10,538,509 · App. 15/301,692 · Granted Jan 21, 2020

Decarboxylative cross-coupling and applications thereof

Inventors: David W. C. MacMillan (Princeton, NJ); Zhiwei Zuo (Plainsboro, NJ)
Assignee: The Trustees of Princeton University
C07D403/04C07C211/27C07D207/06C07D207/08C07D209/14C07D211/08C07D265/30C07D401/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,538,509
App. No.
15/301,692
Granted
Jan 21, 2020
Kind
B2
Abstract

Methods described herein enable the production of numerous molecular species through decarboxylative cross-coupling via use of photoredox and transition metal catalysts. A method described herein, in some embodiments, comprises providing a reaction mixture including a photoredox catalyst, a transition metal catalyst, a coupling partner and a substrate having a carboxyl group. The reaction mixture is irradiated with a radiation source resulting in cross-coupling of the substrate and coupling partner via a mechanism including decarboxylation, wherein the coupling partner is selected from the group consisting of a substituted aromatic compound and a substituted aliphatic compound.

Claims (30)

1. A method of cross-coupling comprising:

providing a reaction mixture comprising a photoredox catalyst, a transition metal catalyst, a coupling partner and a substrate having a carboxyl group; and

irradiating the reaction mixture with a radiation source resulting in cross-coupling of the substrate and coupling partner via a mechanism including decarboxylation, wherein the coupling partner is selected from the group consisting of a substituted aromatic compound and a substituted aliphatic compound.

2. The method of claim 1 , wherein the photoredox catalyst is a transition metal complex.

3. The method of claim 2 , wherein the transition metal complex is an iridium complex or a ruthenium complex.

4. The method of claim 2 , wherein the transition metal complex is a heteroleptic iridium complex.

5. The method of claim 4 , wherein the heteroleptic iridium complex is selected from the group consisting of Ir[dF(CF 3 )ppy] 2 (dtbbpy) + , Ir(ppy) 2 (dtbbpy) + and Ir[dF(5-Me)ppy] 2 (tetraMePhen) + .

6. The method of claim 1 , wherein decarboxylation forms an alkyl radical.

7. The method of claim 1 , wherein the substrate is an aliphatic carboxylic acid.

8. The method of claim 7 , wherein the aliphatic carboxylic acid is an N-protected proline.

9. The method of claim 7 , wherein the aliphatic carboxylic acid is a fatty acid.

10. The method of claim 7 , wherein the aliphatic carboxylic acid is of formula R 1 —CO 2 H, wherein R 1 is selected from the group consisting of -alkyl, -cycloalkyl, -heteroalkyl, -heterocycloalkyl, -alkenyl, -cycloalkenyl, -heteroalkenyl, -heterocycloalkenyl, -alkynyl, -alkyl-aryl, -alkyl-heteroaryl, -alkyl-alkoxy, -alkenyl-aryl, -alkenyl-heteroaryl, -cycloalkyl-aryl, -cycloalkyl-heteroaryl, -cycloalkenyl-aryl, -heterocycloalkenyl-aryl, and -alkenyl-alkoxy.

11. The method of claim 1 , wherein the substrate is a keto acid.

12. The method of claim 11 , wherein the keto acid is an aliphatic keto acid.

13. The method of claim 11 , wherein the keto acid is an aryl keto acid or heteroaryl keto acid.

14. The method of claim 11 , wherein the keto acid is of the formula R 2 —C(O)—CO 2 H, wherein R 2 is selected from the group consisting of -alkyl, -cycloalkyl, -heteroalkyl, -heterocycloalkyl, -alkenyl, -cycloalkenyl, -heteroalkenyl, -heterocycloalkenyl, -alkynyl, -aryl, -heteroaryl, -alkyl-aryl, -alkyl-heteroaryl, -alkyl-alkoxy, -alkenyl-aryl, -alkenyl-heteroaryl and -alkenyl-alkoxy.

15. The method of claim 1 , wherein the cross-coupling is a sp 3 -sp 2 cross-coupling.

16. The method of claim 1 , wherein the cross-coupling is a sp 3 -sp 3 cross-coupling.

17. The method of claim 1 , wherein the substituted aromatic compound is a substituted aryl or substituted heteroaryl.

18. The method of claim 17 , wherein the substituted aryl is an iodo-aryl compound.

19. The method of claim 1 , wherein the substituted aliphatic compound comprises one or more points of unsaturation.

20. The method of claim 1 , wherein the substituted aliphatic compound is saturated.

21. The method of claim 20 , wherein the substituted aliphatic compound comprises a halide leaving group.

22. The method of claim 1 , wherein the carboxyl group of the substrate is in protonated form, deprotonated form, salt form or a carboxylate ester.

23. The method of claim 1 , wherein the mechanism comprises formation of a radical followed by decarboxylation.

24. The method of claim 23 , wherein the formation of the radical includes a single electron transfer process.

25. The method of claim 23 , wherein the radical is a carboxyl radical.

26. The method of claim 24 , wherein the single electron transfer process involves single electron transfer between a transition metal and the substrate.

27. The method of claim 24 , wherein the single electron transfer process involves single electron transfer between photoredox catalyst and the substrate.

28. The method of claim 1 , wherein the photoredox catalyst and transition metal catalyst engage in a single electron transfer process.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2018
From: ZUO, ZHIWEI
To: THE TRUSTEES OF PRINCETON UNIVERSITY
Reel/Frame 047791/0561 →
CONFIRMATORY LICENSE Recorded Dec 23, 2016
From: PRINCETON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041187/0533 →
Continuity (3)
Provisional Application 61975667 · Apr 4, 2014
Provisional Application 62020165 · Jul 2, 2014
Related Publication 20170022185A1 · Jan 26, 2017